Found 62 matching trials
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children PHASE2 Primary Objective:
To evaluate for each influenza strain the non-inferiori...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route) PHASE2 This study is in support of the annual application for the variation of the...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea PHASE4 This study is designed to assess the immunogenicity and safety of the 2010-...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults PHASE2 The trial is a Phase II, open-label trial in healthy subjects aged 18 to 60...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine PHASE2 This study is designed to generate clinical data as outlined in the Note fo...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over PHASE3 The goal of this study is to determine whether the immune responses induced...
Show More Location
University Clinical Research, Inc.
Learn More & Join Trial
Influenza Vaccine Revaccination in Ambulatory Elderly Subjects PHASE2 This is a multi-center study designed to evaluate the safety and immunogeni...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI) PHASE2 The study is a single centre, phase II, double-blind, randomized, comparati...
Show More Location
Kazakh National Medical University
Learn More & Join Trial
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam PHASE3 This was an extensive, double-blind, randomized, placebo-controlled phase 3...
Show More Learn More & Join Trial
Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza PHASE3 To demonstrate that the efficacy over a defined surveillance period against...
Show More Learn More & Join Trial